WPI 3171 (Alendronate 35 mg)
Pill imprint WPI 3171 has been identified as Alendronate sodium 35 mg.
Alendronate is used in the treatment of paget's disease; osteoporosis; prevention of osteoporosis; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WPI 3171 (Alendronate 35 mg)
Alendronate sodium
- Imprint:
-
WPI
3171 - Strength:
- 35 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-3171
| NDC Code | Manufacturer / Repackager |
|---|---|
| 21695-0901 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
More resources
Alendronate sodium is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
